Pawan Bir Kohli

2.6k citations
3 papers · 198 indexed · h-index 3
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 1
    • Cytokine Signaling Pathways and Interactions 2
    • interferon and immune responses 1
    • Pharmacological Effects of Natural Compounds 1
    • Protein Kinase Regulation and GTPase Signaling 2
    • Cell death mechanisms and regulation 1
    • RNA and protein synthesis mechanisms 1

Pawan Bir Kohli

3 papers receiving 191 citations

Peers

Pawan Bir Kohli
Comparison fields: 5 of 37
  • Genetics 62
  • Oncology 113
  • Immunology 55
  • Hematology 29
  • Pharmacology 13
Replace Audrey M. Davies with:
Audrey M. Davies United States
Katherine Labella United States
Iris Leung Canada
Minwei Ye United States
Mai Itoh Japan
Rebekah Baskin United States
Daniel D. Le United States
Charina Ortega United States
Hiroyuki Moritomo Japan
Tianlin Guo Canada
Pawan Bir Kohli relative to Audrey M. Davies United States Audrey M. Davies's profile →
Citations per field
00.5×4.3×
Audrey M. Davies · 1×
Citations per year

Countries citing papers authored by Pawan Bir Kohli

Since Specialization
Citations

This map shows the geographic impact of Pawan Bir Kohli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pawan Bir Kohli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pawan Bir Kohli more than expected).

Fields of papers citing papers by Pawan Bir Kohli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pawan Bir Kohli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pawan Bir Kohli. The network helps show where Pawan Bir Kohli may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Pawan Bir Kohli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pawan Bir Kohli Line = papers co-authored together Pawan Bir Kohli links everyone, so they are left out of the graph.

All Works

About Pawan Bir Kohli

Pawan Bir Kohli is a scholar working on Pharmacology, Genetics and Oncology, having authored 3 papers that have together received 198 indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), interferon and immune responses (1 paper), Cell death mechanisms and regulation (1 paper), RNA and protein synthesis mechanisms (1 paper), Pharmacological Effects of Natural Compounds (1 paper) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). The work is most often cited by research in Genetics (62 citations), Oncology (113 citations) and Immunology (55 citations). Pawan Bir Kohli has collaborated with scholars based in China. Frequent co-authors include Patrick J. Lupardus, Charles Eigenbrot, Adam R. Johnson, Mark Ultsch, Heidi J.A. Wallweber, Sreemathy Ramaswamy, Domagoj Vucic, Snahel Patel, Zhaowu Xu and Jian Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026